The Finnish Diabetes Prevention Study
暂无分享,去创建一个
T. Valle | J. Eriksson | J. Lindström | H. Hämäläinen | P. Ilanne-Parikka | A. Louheranta | M. Rastas | M. Uusitupa | J. Sundvall | J. Tuomilehto | S. Aunola | J Eriksson | M Uusitupa | J Tuomilehto | A Louheranta | J Lindström | T Valle | J Sundvall | V. Martikkala | T. Viljanen | M. Mannelin | P. Lehto | M. Lauhkonen | Matti Uusitupa | Johan G. Eriksson | Jaakko Tuomilehto | Jaana Lindstro
[1] M. Uusitupa. Early lifestyle intervention in patients with non-insulin-dependent diabetes mellitus and impaired glucose tolerance. , 1996, Annals of medicine.
[2] M. Laakso,et al. Diabetes and atherosclerosis: an epidemiologic view. , 1987, Diabetes/metabolism reviews.
[3] M. Uusitupa,et al. Impact of intensified dietary therapy on energy and nutrient intakes and fatty acid composition of serum lipids in patients with recently diagnosed non-insulin-dependent diabetes mellitus. , 1993, Journal of the American Dietetic Association.
[4] C. Sherbourne,et al. The RAND 36-Item Health Survey 1.0. , 1993, Health economics.
[5] R. Hamman. Genetic and environmental determinants of non-insulin-dependent diabetes mellitus (NIDDM). , 1992, Diabetes/metabolism reviews.
[6] B. Howard,et al. Effects of Diet and Exercise in Preventing NIDDM in People With Impaired Glucose Tolerance: The Da Qing IGT and Diabetes Study , 1997, Diabetes Care.
[7] D. Goldstein,et al. Long-term weight loss: the effect of pharmacologic agents. , 1994, The American journal of clinical nutrition.
[8] T. Valle,et al. Prevention of Type II diabetes in subjects with impaired glucose tolerance: the Diabetes Prevention Study (DPS) in Finland Study design and 1-year interim report on the feasibility of the lifestyle intervention programme , 1999, Diabetologia.
[9] R. DeFronzo. PATHOGENESIS OF TYPE 2 DIABETES: METABOLIC AND MOLECULAR IMPLICATIONS FOR IDENTIFYING DIABETES GENES , 1997 .
[10] L. Niskanen,et al. Hyperglycemia and compositional lipoprotein abnormalities as predictors of cardiovascular mortality in type 2 diabetes: a 15-year follow-up from the time of diagnosis. , 1998, Diabetes care.
[11] C Osmond,et al. Fetal and infant growth and impaired glucose tolerance at age 64. , 1991, BMJ.
[12] Daniel L. McGee,et al. Diabetes and cardiovascular disease. The Framingham study. , 1979, JAMA.
[13] Melvin Prince,et al. The Diabetes Prevention Program. Design and methods for a clinical trial in the prevention of type 2 diabetes. , 1999, Diabetes care.
[14] P. Zimmet. Primary Prevention of Diabetes Mellitus , 1988, Diabetes Care.
[15] K. Narayan,et al. Preventing Non-Insulin-Dependent Diabetes , 1995, Diabetes.
[16] P. Zimmet,et al. The Rising Global Burden of Diabetes and its Complications: Estimates and Projections to the Year 2010 , 1997, Diabetic medicine : a journal of the British Diabetic Association.
[17] T. Contributors. The Nutrition Society , 1941, Nature.
[18] M. Uusitupa,et al. The effects of monounsaturated-fat enriched diet and polyunsaturated-fat enriched diet on lipid and glucose metabolism in subjects with impaired glucose tolerance. , 1996, European journal of clinical nutrition.
[19] Alain Golay,et al. Randomised placebo-controlled trial of orlistat for weight loss and prevention of weight regain in obese patients , 1998, The Lancet.
[20] M. Laakso,et al. NIDDM and Its Metabolic Control Predict Coronary Heart Disease in Elderly Subjects , 1994, Diabetes.
[21] Richard Barnett,et al. Diabetes mellitus. , 1993, The Medical journal of Australia.
[22] B. Kahn,et al. Glucose transporters and insulin action--implications for insulin resistance and diabetes mellitus. , 1999, The New England journal of medicine.
[23] W. Kannel,et al. Diabetes and cardiovascular disease. The Framingham study. , 1979, JAMA.